Vimeo
LinkedIn
Instagram
Share |

research and development

April 28, 2020

The coronavirus pandemic has triggered a race for disruptive innovation in diagnostics, new therapies and novel vaccines, but the global life sciences industry was already expected to reach more than $2 trillion in gross value by 2023, up from $1.6 trillion before the crisis.

The coronavirus pandemic has triggered a race for disruptive innovation in diagnostics, new therapies and novel vaccines, but the global life sciences industry was already expected to reach more than $2 trillion in gross value by 2023, up from $1.6 trillion before the crisis.

August 7, 2014

Almost two decades since the concept of disruptive innovation was thrust into public consciousness, companies have both risen and fallen prey to the process. Kodak was a loser, Amazon was a winner, and the iPhone alone has disrupted a number of technologies – cameras, alarm clocks and radios, to name a few.

Almost two decades since the concept of disruptive innovation was thrust into public consciousness, companies have both risen and fallen prey to the process. Kodak was a loser, Amazon was a winner, and the iPhone alone has disrupted a number of technologies – cameras, alarm clocks and radios, to name a few.

But this June Harvard Business School professor Jill Lepore argued it was time to give the concept (whereby new innovations suddenly shake up the marketplace, replacing predecessor technologies) a rest.

Click here >>
Close